A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Seagen Inc.
Seagen Inc.
Abramson Cancer Center at Penn Medicine
Hoffmann-La Roche
University of California, Irvine
Daiichi Sankyo
UNICANCER
I-Mab Biopharma US Limited
Tempus AI
British Columbia Cancer Agency
University of California, Irvine
Elevation Oncology
Novartis
Merck Sharp & Dohme LLC
Rutgers, The State University of New Jersey
University Hospital, Ghent
Hoffmann-La Roche
Jules Bordet Institute
Bayer
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
University of Arizona
Nottingham University Hospitals NHS Trust
Amgen
Sound Pharmaceuticals, Incorporated
Merck Sharp & Dohme LLC
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Novartis
Dana-Farber Cancer Institute
Papworth Hospital NHS Foundation Trust
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
GE Healthcare
GE Healthcare
Siemens Molecular Imaging
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Fox Chase Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Hoag Memorial Hospital Presbyterian
Aposense Ltd.